Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early initiation of GnRH antagonist in poor responder patients
IRCT20110731007165N9Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2019
- Countries
- 1
01
Overview
Phase 3 trial of relugolix in poor ovarian response (POR), sponsored by Tehran University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
relugolix
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20110731007165N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110731007165N9.